Het Maasstad Ziekenhuis is de huidige naam van de gefuseerde ziekenhuizen Zuiderziekenhuis en Sint Clara Ziekenhuis in Rotterdam-Zuid. Op 1 januari 2000 zijn de twee ziekenhuizen eerst gefuseerd tot Medisch Centrum Rijnmond-Zuid. Op 1 september 2008 is de naam gewijzigd in het huidige Maasstad Ziekenhuis.

During the past decade, Maasstad Ziekenhuis conducted 113 clinical trials. In the 10-year time frame, 113 clinical trials started and 18 clinical trials were completed, i.e. on average, 15.9% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 14 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maasstad Ziekenhuis" #1 sponsor was "Erasmus Medical Center" with 22 trials, followed by "Maasstad Hospital" with 15 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Abbott Medical Devices" with 6 trials sponsored and "Radboud University Medical Center" with 6 trials sponsored. Other sponsors include 99 different institutions and companies that sponsored additional 77 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maasstad Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 10 trials as a collaborator, "Maasstad Hospital" with 8 trials as a collaborator, "Erasmus Medical Center" with 7 trials as a collaborator, "UMC Utrecht" with 7 trials as a collaborator and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 6 trials as a collaborator. Other collaborators include 182 different institutions and companies that were collaborators in the rest 147 trials.

According to Clinical.Site data, the most researched conditions in "Maasstad Ziekenhuis" are "Coronary Artery Disease" (20 trials), "Breast Cancer" (7 trials), "Coronary Disease" (4 trials), "Coronary Restenosis" (4 trials) and "Burns" (3 trials). Many other conditions were trialed in "Maasstad Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Maasstad Ziekenhuis" are "Drug" (70 trials), "Device" (35 trials), "Other" (29 trials), "Procedure" (18 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Ocrelizumab" (4 trials), "Bevacizumab" (3 trials), "Rituximab" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Maasstad Ziekenhuis" are 143 trials for "All" genders, 12 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Maasstad Ziekenhuis". 4 are not yet recruiting, 31 are recruiting, 32 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 69 completed trials in Maasstad Ziekenhuis, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Maasstad Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 44 trials that are defined as “Not Applicable".

Maasstad Ziekenhuis has several departments that took part in Clinical trials: "Maasstadziekenhuis; Reumatologie" - 2 trials